Background: Single room isolation with contact precautions is widely regarded as a fundamental strategy to prevent the transmission of multidrug-resistant organisms (MDROs). However, its implementation demands substantial resources, limiting its universal application to all MDROs. In this study, we assessed the effect of discontinuing single room isolation for vancomycin-resistant (VRE).
Methods: This is a retrospective, observational study conducted at a single 750-bed tertiary center. We conducted an interrupted time series analysis to compare incidence rates and trends of new-onset VRE colonization and bacteremia during the one year before and after the strategy change on January 1, 2023.
Results: Single-room occupancy decreased from 79.7% pre-intervention to 23.6% post-intervention ( < 0.001). The incidence rate of new-onset VRE colonization was 0.452 and 0.535 per 1,000 patient-days in the pre- and post-intervention periods, respectively, with no statistically significant difference ( = 0.202). However, there was a slightly increasing trend (0.036 [95% confidence interval, -0.002, 0.074] increase per month, = 0.066). The new-onset VRE bacteremia incidence rate was not differed in incidence (0.060 and 0.055, = 0.571) or trend ( = 0.720).
Conclusion: Our study suggests that discontinuing single-room isolation for VRE patients may not affect the incidence of new-onset VRE bacteremia, but caution is needed due to the potential increase in colonization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11810633 | PMC |
http://dx.doi.org/10.3346/jkms.2025.40.e11 | DOI Listing |
J Korean Med Sci
February 2025
Center for Infection Prevention and Control, Samsung Changwon Hospital, Changwon, Korea.
Background: Single room isolation with contact precautions is widely regarded as a fundamental strategy to prevent the transmission of multidrug-resistant organisms (MDROs). However, its implementation demands substantial resources, limiting its universal application to all MDROs. In this study, we assessed the effect of discontinuing single room isolation for vancomycin-resistant (VRE).
View Article and Find Full Text PDFAm J Infect Control
November 2023
Department of Pharmacy, Foothill Medical Center, Alberta Health Services, Calgary, Alberta, Canada.
Background: Clostridioides difficile infection (CDI) is principally health care-associated, with a substantial impact on morbidity and mortality. The guidelines recommend CDI therapy for 10 days; however, it is often extended in practice when concurrent antibiotics are used. The impact of the extended duration of therapy remains unclear.
View Article and Find Full Text PDFCase Rep Gastroenterol
October 2020
Department of Gastroenterology, Oncology and Diabetology, Teaching Hospital of University of Heidelberg, Theresienkrankenhaus and St. Hedwig Klinik GmbH, Mannheim, Germany.
We describe the case of a 71-year-old woman who presented with obstructive jaundice and subhilar bile duct stenosis. MRI showed extensive cholecystolithiasis with an impacted bile stone in the cystic duct suggesting Mirizzi syndrome. Delayed enhancement of the thickened gallbladder wall suggested inflammation instead of carcinoma.
View Article and Find Full Text PDFOpen Forum Infect Dis
January 2020
Division of Geriatrics and Palliative Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Background: The clinical utility of patient and environmental surveillance screening for vancomycin-resistant enterococci (VRE) in the postacute care setting has not been definitively clarified. We assessed the longitudinal relationship between patient colonization and room contamination, and we established their association with unfavorable health outcomes.
Methods: Four hundred sixty-three postacute care patients were followed longitudinally from enrollment to discharge for up to 6 months.
Antimicrob Agents Chemother
September 2013
New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.
The feasibility of fidaxomicin versus vancomycin and metronidazole (conventional therapy) was assessed in 59 transplant recipients with 61 episodes of Clostridium difficile-associated diarrhea (CDAD). Overall clinical cure was achieved in 86% of episodes, and in 7% of episodes, infection recurred. Fidaxomicin was well tolerated.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!